OxThera Company

OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.

Founded Date: 2005
Last Funding Type: Seed
Headquarters: Stockholm, Stockholms Lan, Sweden
Investors Number: 10
Technology: Others
Employee Number: 11-50
Industry: PharmTech
Estimated Revenue: $10M to $50M
Funding Status: Late Stage Venture
Investor Type: For Profit
Total Funding: €4.9M